Kempf, Christoph

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

2016

von Nordheim, Marcus; Boinay, Michel Thomas; Leisi, Remo; Kempf, Christoph; Ros, Carlos (2016). Cutthroat Trout Virus-Towards a Virus Model to Support Hepatitis E Research. Viruses, 8(10), p. 289. Molecular Diversity Preservation International MDPI 10.3390/v8100289

Leisi, Remo; von Nordheim, Marcus; Ros, Carlos; Kempf, Christoph (2016). The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells. Viruses, 8(10), p. 265. Molecular Diversity Preservation International MDPI 10.3390/v8100265

Wolfisberg, Raphael; Kempf, Christoph; Ros, Carlos (2016). Late Maturation Steps Preceding Selective Nuclear Export and Egress of Progeny Parvovirus. Journal of virology, 90(11), pp. 5462-5474. American Society for Microbiology 10.1128/JVI.02967-15

Leisi, Remo; Di Tommaso, Chiarina; Kempf, Christoph; Ros, Carlos (2016). The Receptor-Binding Domain in the VP1u Region of Parvovirus B19. Viruses, 8(3), p. 61. Molecular Diversity Preservation International MDPI 10.3390/v8030061

2015

Leisi, Remo; von Nordheim, Marcus; Kempf, Christoph; Ros, Carlos (2015). Specific Targeting of Proerythroblasts and Erythroleukemic Cells by the VP1u Region of Parvovirus B19. Bioconjugate chemistry, 26(9), pp. 1923-1930. American Chemical Society 10.1021/acs.bioconjchem.5b00321

2013

Kempf, Christoph; Leisi, Remo; Ros, Carlos; Ruprecht, Nico (2013). Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism. Journal of virology, 87(24), pp. 13161-13167. American Society for Microbiology 10.1128/JVI.02548-13.

Wolfisberg, Raphael; Ruprecht, Nico; Kempf, Christoph; Ros, Carlos (2013). Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19. Journal of virological methods, 193(1), pp. 215-225. Elsevier 10.1016/j.jviromet.2013.06.003

Cai, Kang; Gröner, Albrecht; Dichtelmüller, Herbert O.; Fabbrizzi, Fabrizio; Flechsig, Eckhard; Gajardo, Rodrigo; von Hoegen, Ilka; Jorquera, Juan I.; Kempf, Christoph; Kreil, Thomas R.; Lee, Douglas C.; Moscardini, Mila; Pölsler, Gerhard; Roth, Nathan J. (2013). Prion removal capacity of plasma protein manufacturing processes. Transfusion, 53(9), pp. 1894-1905. Wiley-Blackwell 10.1111/trf.12050

Kempf, Christoph; Späth, Peter Julius (2013). Pathogen safety of Immunoglobulin Preparations. In: Clinical use of immunoglobulins (pp. 33-57). Bremen: UNI-med

2012

Quattrocchia, Silva; Ruprechta, Nico; Bönscha, Claudia; Bielia, Sven; Zürchera, Christoph; Bollerb, Klaus; Kempf, Christoph; Ros, Carlos (2012). Characterization of the Early Steps of Human Parvovirus B19 Infection. Journal of virology, 86(17), pp. 9274-9284. Baltimore: American Society for Microbiology 10.1128/JVI.01004-12

Quattrocchi, S.; Ruprecht, N.; Bonsch, C.; Bieli, S.; Zurcher, C.; Boller, K.; Kempf, C.; Ros, C. (2012). Early steps of human parvovirus B19 infection. In: USGEB Annual Meeting 2012.

Quattrocchi, S.; Ruprecht, N.; Bonsch, C.; Bieli, S.; Zurcher, C.; Boller, K.; Kempf, C.; Ros, C. (2012). Characterization of the Early Steps of Human Parvovirus B19 Infection. In: XIV International Parvovirus Workshop.

2011

Dichtelmüller, Herbert O.; Biesert, Lothar; Fabbrizzi, Fabrizio; Falbo, Anna; Flechsig, Eckhard; Gröner, Albrecht; von Hoegen, Ilka; Kempf, Christoph; Kreil, Thomas R.; Lee, Douglas C.; Pölsler, Gerhard; Roth, Nathan J. (2011). Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion, 51(7), pp. 1412-1430. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2010.03003.x

Zuercher, Adrian W.; Amsler, Lorenz; Amstutz, Hanspeter; Andresen, Irmgard; Bolli, Reinhard; Hummel, Wolfram; Käsermann, Fabian; Kempf, Christoph; Lerch, Peter; Lörtscher, Marius; Schaub, Alexander; Spycher, Martin; Miescher, Sylvia M. (2011). C2 Plasma-derived immunoglobulins. In: Nijkamp, Frans P.; Parnham, Michael J. (eds.) Principles of Immunopharmacology, Part 3 (pp. 271-301). Heidelberg: Springer Verlag 10.1007/978-3-0346-0136-8_17

2010

Bönsch, Claudia; Zuercher, Christoph; Lieby, Patricia; Kempf, Christoph; Ros, Carlos (2010). The globoside receptor triggers structural changes in the B19V capsid that facilitate virus internalization. Journal of virology, 84(22), pp. 11737-11746. Baltimore: American Society for Microbiology 10.1128/JVI.01143-10

Bönsch, Claudia; Kempf, Christoph; Müller, Ivo; Manning, Laurens; Laman, Moses; Davis, Timothy M.E.; Ros, Carlos (2010). Chloroquine and Its Derivatives Exacerbate B19V-Associated Anemia by Promoting Viral Replication. PLoS neglected tropical diseases, 4(4), e669. San Francisco, Calif.: Public Library of Science 10.1371/journal.pntd.0000669

2009

Dichtelmüller, Herbert O.; Biesert, Lothar; Fabbrizzi, Fabrizzio; Gajardo, Rodriguez; Gröner, Albrecht; von Hoegen, Ilka; Jorquera, Juan I.; Kempf, Christoph; Kreil, Thomas R.; Pifat, Dominique; Osheroff, Wendy; Poelsler, Gerhard (2009). Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies. Transfusion, 49(9), pp. 1931-1943. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2009.02222.x

2008

Boensch, Claudia; Kempf, Christoph; Ros, Carlos (2008). Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. Journal of virology, 82(23), pp. 11784-11791. Baltimore: American Society for Microbiology 10.1128/JVI.01399-08

Stucki, Martin; Boschetti, Nicola; Schäfer, Wolfram; Hostettler, Thomas; Käsermann, Fabian; Nowak, Thomas; Gröner, Albrecht; Kempf, Christoph (2008). Investigations of prion and virus safety of a new liquid IVIG product. Biologicals, 36(4), pp. 239-247. London: Elsevier 10.1016/j.biologicals.2008.01.004

2007

Kempf, Christoph; Stucki, Martin; Boschetti, Nicola (2007). Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins. Biologicals, 35(1), pp. 35-42. London: Elsevier 10.1016/j.biologicals.2006.01.002

Mani, Bernhard; Gerber, Marco; Lieby, Patricia; Boschetti, Nicola; Kempf, Christoph; Ros, Carlos (2007). Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion, 47(10), pp. 1765-1774. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2007.01393.x

Ros, Carlos; Gerber, Marco; Kempf, Christoph (2007). Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity. Journal of virology, 80(24), pp. 12017-12024. Baltimore: American Society for Microbiology 10.1128/JVI.01435-06

Borte, M; Horneff, G; Kempf, Christoph; Kaise, R; Korinthenberg, R; Körholz, D; Mauz-Körholz, C; Nadal, D; Niggemann, B; Roos, R; Späth, Peter; Wahn, V; Wehmeier, A; Zepp, F; Zielen, S (2007). Herstellung von intravenös verabreichbaren Immunglobulinen und Pathogensicherheit. In: Wahn, Volker (ed.) Klinischer Einsatz von Immunglobulinen (pp. 28-47). Bremen et al.: UNI-MED

2006

Ros, Carlos; Baltzer, Claudia; Mani, Bernhard; Kempf, Christoph (2006). Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability. Virology, 345(1), pp. 127-147. New York, N.Y.: Academic Press 10.1016/j.virol.2005.09.030

Mani, Bernhard; Baltzer, Claudia; Valle, Noelia; Almendral, José; Kempf, Christoph; Ros, Carlos (2006). Low pH-dependent endosomal processing of the incoming parvovirus MVM virion leads to N-VP1 externalization, N-VP2 cleavage and uncoating of the full-length genome. Journal of virology, 80(2), pp. 1015-1024. Baltimore: American Society for Microbiology 10.1128/JVI.80.2.1015-1024.2006

Bauman, P; Lawrence, LA; Biesert, L; Dichtelmüller, H; Fabbrizzi, F; Gajardo, R; Gröner, A; Jorquera, JI; Kempf, Christoph; Kreil, TR; von Hoegen, I; Pifat, DY; Petteway, SR Jr; Cai, K (2006). Critical factors influencing prion inactivation by sodium hydroxide. Vox sanguinis, 91(1), pp. 34-40. Oxford: Wiley-Blackwell 10.1111/j.1423-0410.2006.00790.x

Käsermann, Fabian; Kempf, Christoph (2006). Virus membrane proteins and proteinaceous pores. Future virology, 1(6), pp. 823-831. London: Future Medicine Ltd. 10.2217/17460794.1.6.823

Käsermann, Fabian; Jürs, Mathias; Kempf, Christoph (2006). Prionen Erkrankungen beim Menschen und die Sicherheit von Blut und plasmatischen Produkten. In: Seifried, Erhard (ed.) Quo vadis Plasmaproteine (pp. 20-33). München: Gesellschaft für Thrombose- und Hämostaseforschung

Provide Feedback